Please assess the completion status of the following clinical trial:

Trial Title: Prospective Randomized Study to Evaluate the Effect of Embryonic Observation on the Gestation (PROdE)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* First cycle of ART treatment with conventional IVF or ICSI with donated eggs.~* Normal uterine cavity and a single or double embryo transfer, always performed on day 5 at blastocyst stage.~Exclusion Criteria:~* Patients above 50 years old, patients that were diagnosed with recurrent implantation failure (RIF) and/or recurrent pregnancy loss (RPL) or uterine pathologies,~* Body mass index \>30 kg/m2.~* The use of seminal samples coming from donors or testicular origin.~* Cycles that included preimplantational genetic testing (PGT).

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- No embryo observation (NEO) (Type: NO_INTERVENTION): Study group. No embryonic observation from day one to day five of embryo development.
- Embryo observation (EO) (Type: EXPERIMENTAL): Control group. Conventional embryonic observations performed in day two, three and five of embryo development.

Based on this trial design, predict the completion outcome and termination type (if applicable).